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Abstract 
 
 
It is well known that G1 to S phase transition is tightly regulated by the expression and 
phosphorylation of a number of well characterised Cyclins, Cyclin Dependent kinases and 
members of the retinoblastoma gene family. In this review we discuss the role of these 
components in regulation of G1 to S phase transition in somatic cells and human embryonic stem 
cells. Most importantly, we discuss some new tenable links between maintenance of 
pluripotency and cell cycle regulation in ESC by describing the role that master transcription 
factors play in this process. Finally, the differences in cell cycle regulation between murine and 
human ESC are highlighted raising interesting question on their biology and stages of embryonic 
development from which they have been derived.  
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1. Focus of the review 
A large body of literature suggests that the cell’s decision to differentiate, proliferate, apoptose, 
become quiescent or enter into senescent arrest is often made in the G1 phase of the cell cycle. 
One key difference between somatic and embryonic stem cells is the length of G1 phase during 
which cells prepare for S phase entry. Recent studies have shown that the length of G1 phase in 
embryonic stem cells (ESC) is much shorter as compared to somatic cells (Becker et al. 2006, 
Savatier et al., 1994; Fluckiger et al., 2006). A few studies have shown that lengthening of G1 
phase of the cell cycle results in loss of undifferentiated phenotype and induction of 
differentiation in neural stem cells, thus suggesting some close links between cell cycle 
regulation and stem cell potency (Calegari and Huttner, 2003).  It is therefore very important to 
understand the mechanisms that govern the G1 to S phase progression in detail in both somatic 
and embryonic stem cells. 
 
2. Summary of pathways that govern G1 to S transition in somatic cells 
In differentiated mammalian cells, G1 to S progression is regulated by hypophosphorylated Rb 
gene or its related proteins, p107 and p130 which inhibit the expression of genes required for 
entry into S phase by sequestering the E2F family of transcription factors. During G1 phase the 
Rb/HDAC repressor complex binds to the E2F-DP1 transcription factors inhibiting downstream 
transcription (for a schematic view see Figure 1A). Eukaryotic cell cycle progression is 
dependent, in part, on the tightly regulated activity of Cyclin dependent kinases (Cdks). 
Cdk4/Cdk6 and Cdk2 whose regulatory partners are the D type Cyclins (D1, D2 and D3) and 
Cyclin E respectively represent two different classes of G1 specific Cdks whose activation is 
required for entry into S phase. Cyclin D/CDdk4-Cdk6 activity occurs in mid-late G1 phase, 
upstream of Cdk2/Cyclin E activity. Under conditions favouring proliferation, the inactivating 
phosphorylation of Rb by the Cdks in mid to late G1 results in liberation of E2F and other Rb-
bound transcription factors that then activate transcription of S-phase genes (Figure 2A). This 
induces a partial release of the E2F gene which is sufficient to activate transcription of Cyclin E 
and Cdc25A. This point in the cell cycle is known as the restriction point (Pardee, 1974). Cyclin 
protein levels oscillate throughout the cell cycle, and their availability is a mean of controlling 
Cdk activity and cell proliferation.  
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A second related pathway is thought to involve the c-Myc gene which stimulates directly the 
expression of Cyclin E and Cdc25a gene (Figure 1). Working against the mitogenic activity of 
CDKs are cell cycle inhibitory proteins which include p15INK4B, p16INK4A, p18INK4C, p19INK4D, 
p21CIP, p27Kip1 and p57Kip2. It is thought that Cyclin D/Cdk complexes also play a second non-
catalytic role in G1 progression by sequestering proteins of the Cip/Kip family, including p27 
Kip1 and p21Cip1, two potent inhibitors of Cdk2 (Sherr and Roberts, 1995). Binding of Cip/Kip 
proteins to CyclinD1/Cdk4 stabilizes the complex and facilitates its nuclear import (Cheng et al., 
1999). Mitogen withdrawal results in the disassembly of the Cyclin D–Cdks and in addition 
mobilizes the latent pool of p27Kip1, which blocks the activity of CyclinE/Cdk2 and facilitates 
cell cycle exit (Sherr and Roberts, 1995). Murine embryonic fibroblasts (MEFs) lacking p27 and 
p21 do not express D-type Cyclins and have a significant reduction in Cdk activity, but 
nevertheless proliferate normally (Cheng et al., 1999). This suggests that D-type Cyclins might 
not be essential for cell cycle progression, at least in a setting where Cip/Kip proteins are absent. 
Further studies showed that activation of Cyclin D1/Cdk4 complex occurs when quiescent 
p21/p27– null MEFs are stimulated to re-enter the cell cycle (Sugimoto et al., 2002). In addition 
the ectopic expression of p34 SEI-1, a mitogen- induced  Cdk4 activator increased the levels of 
active Cyclin D1/Cdk4 complex in the absence of p21 and p27, suggesting that there are several 
independent ways to stimulate the assembly of Cyclin D1/Cdk4 complex (Sugimoto et al., 2002). 
 
More recent studies have highlighted the role of an additional cell cycle regulatory mechanism at 
the G1 to S transition that is able to govern the initiation of histone gene expression needed for 
packaging of newly replicated DNA (reviewed by Stein et al. 2006; Figure 2A). This is 
commonly referred as S point and is initiated by Cyclin E/Cdk2 dependent phosphorylation of 
p220NPAT and the formation of a functional HiNF-p220NPAT complex that controls H4 gene 
transcription (see Figure 2A). Although both pathways have been extensively characterised in 
some detail in somatic cells, less information is available in embryonic stem cells. In this review 
we will focus on the role of these two pathways in somatic cells and draw comparisons to 
embryonic stem cells. 
 
3. Roles of D-type cyclins in somatic cell proliferation  
In 1995, the phenotype of mice lacking Cyclin D1 gene was reported (Fantl et al., 1995; Sicinski 
et al., 1995). These studies showed that mice lacking Cyclin D1 were viable and exhibited only 
focal developmental anomalies confined to the retina and a predisposition to develop breast 
cancer during pregnancy. Later, mice lacking one or more D type Cyclins were obtained 
(Ciemerych et al., 2002; Kozar et al., 2004) and like cyclin D1 deficient mice, animals lacking 
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Cyclin D2 or Cyclin D3 were viable and exhibited only very specific deficits. The loss of Cyclin 
D2 compromised female fertility, postnatal cerebellar development and impaired the mitogen-
dependent expansion of peripheral B-lymphocytes (Sicinski et al., 1996).  Cyclin D3 inactivation 
affected the early steps of lymphocytes maturation in the thymus that depends on the pre-T cell 
receptor (Sicinska et al., 2003). These studies revealed that the tissues most affected by 
disruption of the Cyclin D genes were those that principally express only one D-type Cyclin. 
Hence, tissue – specific expression patterns of the different D-type Cyclins seems to determine 
the pathologic manifestations that arise from their individual elimination. However, during early 
embryonic development animals retaining only one D-type Cyclin lose the tissue specific 
expression characteristic of that gene and up-regulate the remaining  D-Cyclin in most tissues in 
order to compensate for loss of the other D type Cyclins (Ciemerych et al., 2002).  
 
It has been suggested that the apparently normal organogenesis (at least until midgestation) 
observed in single D-Cyclin knock out mice can be explained by the ubiquitous expression of the 
remaining D-type Cyclins. A second possibility is that normal development in some lineages is 
likely to proceed independently of the D type Cyclins. The generation of mice lacking all three 
D-type cyclins has now shown that the latter is most likely, and those D-Cyclin independent cell 
cycles may be much more widespread than initially suggested (Kozar et al., 2004). The Cyclin 
D1-/-D2-/-D3-/- mice develop until late gestation (day E17.5) and die due to heart abnormalities 
combined with severe anaemia that has been linked to requirement for D Cyclins in the 
expansion of haematopoietic cells. In contrast, Cyclin-deficient fibroblasts proliferate nearly 
normally but show an increased requirement for mitogenic stimulation in cell cycle re-entry. 
Expression studies have shown that the level of other cell cycle regulators, including Cyclins E 
and A, Cdk4, Cdk6 and Cdk2 are unaffected by Cyclin D loss. In addition, these cells are 
resistant to Cyclin D–dependent kinase inhibitor p16Ink4a; however they are critically dependent 
on Cdk2 (Kozar et al., 2004). Downregulation of Cdk2 strongly inhibits proliferation of MEFs 
lacking all three D-type Cyclins (Kozar et al., 2004), suggesting that Cdk2 might substitute for 
the lack of cyclin D/Cdk-dependent kinase activity during mouse development (Sherr and 
Roberts, 2004). This is however true for differentiated cells such as MEFs but not for stem cells, 
since in vitro studies have indicated that the loss of all D-type Cyclins abolishes the ability for 
long-term reconstitution of hematopoietic stem cells and multipotential progenitors raising the 
possibility that D type Cyclins may be essential for self-renewing stem and precursor cell 
populations to progress through the cell cycle. It is also possible that the requirement for D-type 
cyclins may be evident only after these factors have declined below a critical level or after 
inhibitors have accumulated above a threshold (Sherr and Roberts, 2004).  
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Cyclin D1 is overexpressed in many human cancers as a result of gene amplification or 
translocations targeting this locus on human chromosome 11q13 ( Sherr, 1996). A direct role for 
Cyclin D1 involvement in oncogenesis is supported by studies with transgenic mice, in which 
targeted overexpression of Cyclin D1 in mammary epithelial cells leads to tumour formation 
(Sherr, 1996). Mice lacking Cyclin D1 expression show profound defects in mammary 
lobuloalveolar development during pregnancy, indicating that Cyclin D1 plays a critical role in 
the maturation of this tissue. Although none of the components of the Cyclin D/Cdk complexes 
are required in early embryogenesis, specific inhibition of Cyclin D1 in cancer cell lines results 
in cell-cycle arrest (Lee et al., 2000). Most importantly, Cyclin D1 or Cdk4 null mice are 
resistant to breast cancers triggered by the ErbB2 oncogene (Landis et al., 2006) or c-myc 
overexpression (de Marval et al., 2004), thus suggesting an important role for Cyclin D1/Cdk 
activity in neoplastic transformation and highlighting important differences between somatic cell 
proliferation during early embryogenesis and cancer initiation.  
 
4. The role of Cdk4, Cdk6 and Cdk2 in somatic cell proliferation  
Mice lacking Cdk6 or Cdk4 are viable (Malumbres et al., 2004), although most Cdk4 null males 
and females are sterile because of low sperm counts and defects in the hypothalamic-pituitary 
axis that affects the female oestrus cycle. Cdk4 is also essential for the development of β-islet 
cells in the pancreas and these results in insulin-dependent diabetes in these mice. Cdk4-null 
MEFs proliferate normally in serum containing media, however, only a fraction of these cells are 
able to respond to serum stimulation and to re-enter the cell cycle from a quiescent state induced 
by serum starvation (Tsutsui et al., 1999). Mice lacking both Cdk4 and Cdk6 survive to 
midgestation (E14.5) and exhibit megaloblastic anaemia and failure of haematopoiesis, similarly 
to Cyclin D null mice. MEFs deficient in both Cdks are partially able to respond to mitogenic 
stimulation and to exit quiescence. Interestingly, these cells continue to synthesize D-type 
Cyclins, which can directly bind to and activate Cdk2 in vitro (Matsushime et al., 1992). This is 
supported by experimental observations showing that complexes between Cyclin D2 and Cdk2 
are more abundant in MEFs lacking Cdk4 and Cdk6 than in wild-type MEFs (Malumbres et al., 
2004).  Knockdown of Cdk2 inhibits the proliferation of Cdk4/6 –deficient MEFs, but not their 
wild-type counterparts, indicating that Cdk2 can compensate for the loss of Cdk4 and Cdk6. The 
earlier embryonic lethality of mice lacking three D-type cyclins as compared to those with 
double deficient in Cdk4/6 reflects the ability of the D-type Cyclins to activate Cdk2 in a latter 
setting (Sherr and Roberts, 2004). Thus, both models (double knock out for Cdk4 and Cdk6 and 
triple knockout for Cyclin Ds) indicate that D-type Cyclins/Cdk4 and Cdk6 complexes are 
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involved in development of haematopoietic lineage, but that, overall, they have little effect on 
cell proliferation and organogenesis. Analysis of MEFs confirmed that inactivation of Cdk4/6 or 
D-type Cyclins delays S-phase entry (or re-entry after serum starvation), but does not prevent 
proliferation (Kozar et al., 2004; Malumbres et al., 2004).  
 
Viability of Cdk2 null mice was reported in 2003 by Berther (Berther et al., 2003) and Ortega 
(Ortega et al., 2003). Cdk2-null MEFs proliferate normally, with a decreased ability to exit 
quiescence and/or enter S phase at the normal rate. Cyclin A–associated kinase activity is 
reduced in Cdk2 null MEFs from young mice but was not detected in Cdk2 –deficient adult 
spleen cells and in immortalized MEFs (Berthet et al., 2003). However, when Cdk2-/-Cdk6-/- 
mice were generated (Malumbres et al., 2004), it was reported that MEFs from these mice 
demonstrated a significantly lower proliferation rate compared to Cdk2 null MEFs, indicating 
that at least one of these Cdks is required for G1/S phase transition. It is of interest that in 
contrast to Cdk2-/- Cdk6-/- mice which are viable, Cdk2-/-Cdk4-/- and Cdk4-/-Cdk6-/- mutants 
are embryonic lethal at E15 (Berthet et al., 2006). This indicates intrinsic differences between 
Cdk4 and Cdk6 and points to a role for Cdk4 or Cdk6 on cell viability (Malumbres et al., 2004). 
It is likely that Cdk4 can phosphorylate Rb more efficiency than Cdk6, or may be Cdk4 has other 
substrates as compared to Cdk6 (Berthet et al., 2006). Also it was shown that loss of Cdk2 and 
Cdk4 causes hypophosphorylation of Rb, which leads to repression of E2F-target gene 
expression. For example, Cdc2 and Cyclin A2 cease to be expressed, resulting in cell cycle 
defect. This shows that Cdk2 and Cdk4 are important for the regulation of Rb in vivo and for 
Cdc2 (Cdk1) expression (Berthet at al., 2006).   
 
In addition to Cdk2, Cdk4 and Cdk6, mammalian cells express many additional cyclins and Cdks 
that have not been fully studied, and these may provide compensating mechanism(s) in G1 
phase. One such example is Cdk1 whose knock-down causes lethality at the very early stages of 
development (Martin et al., 2005). Although this suggests that Cdk2 and other Cdks are unable 
to compensate for Cdk1, the opposite can be true. Cdk1 can compensate for Cdk2 in Cdk2-/- 
p27-/- mice and can bind to Cyclin E, thus allowing G1/S transition (Aleem et al., 2005). Cdk1 
and Cdk2 have the same cyclin binding partners, A-, B-, and E-type cyclins, but published data 
suggests that Cdk1 shows much higher kinase activity during M phase than Cdk2; however a 
direct comparison in kinase assays has not been published yet (Bashir and Pagano, 2005). 
Nevertheless, Cdk2 is essential for meiosis, indicating that Cdk1 cannot compensate for Cdk2 in 
germ cells (Berthet et al., 2003; Ortega et al., 2003). A recent publication has shown that mouse 
embryos lacking all interphase Cdks (Cdk2, Cdk3, Cdk4 and Cdk6) undergo organogenesis and 
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develop to midgestation. In these embryos, Cdk1 binds to all Cyclins, resulting in the 
phosphorylation of the retinoblastoma protein pRb and the expression of genes that are regulated 
by E2F transcription factors. However, these embryos fail to develop to the morula and 
blastocyst stages in the absence of Cdk1. These results indicate that Cdk1 is the only essential 
cell cycle Cdk. Moreover, they show that in the absence of interphase Cdks, Cdk1 can execute 
all the events that are required to drive cell division (Santamaria et al. 2007). 
 
 
Specific polypeptide inhibitors of CDK4 and CDK6 –the so –called INK4-proteins –can directly 
block CyclinD-dependent kinase activity and cause G1 phase arrest (Figure 1A; Sherr, 1996). 
The four known 15-to 19-kD INK4 proteins (p16INK4a, p15INK4b, p18INK4c and p19INK4d) 
bind and inhibit Cdk4 and Cdk6, but not other Cdks. Thus, INK4 proteins are able to inhibit 
Cyclin D –dependent kinases and further phosphorylation of Rb. 
 
Deregulated activity of Cdk4 and Cdk6 can lead to inappropriate cellular proliferation and 
tumorigenesis. Certain tumor types preferentially activate either Cdk4 or Cdk6, suggesting that 
these kinases may not be equivalently oncogenic in all cell types (Grossel et al., 1999). 
Overexpression of Cdk6 in certain cancer cell line causes an accelerated progression through G1 
phase that is dependent on kinase activity and that does not correlate with p27 binding. In 
addition to the regulation by these inhibitors, Cyclin/Cdk complex are regulated by reversible 
phosphorylation.   
 
Cyclin/Cdk activity is also controlled by the CDK-activating kinase (CAK).This complex 
composed of Cyclin H1, a kinase subunit Cdk7 and a assembly protein Mat1, catalyses 
activating phosphorylation of Cyclin/Cdk complexes at a threonine residue of the Cdks. Cyclin 
H/Cdk7/Mat1 can phosphorylate and activate Cdc2, Cdk2, Cdk3, Cdk4 and Cdk6 complexes in 
vitro (Kaldis, 1999). Mouse Mat1 deficient embryos do not display any proliferative defects at 
the beginning of preimplantation stages, while maternally inherited stock of Mat1 are still 
available. However, they become lethal at E3.5, and this probably reflects the depletion of 
maternal Mat1 protein below threshold levels.  In vitro, Mat1-/- blastocysts give rise to viable 
post-mitotic trophoblast giant cells, while mitotic lineages fail to proliferate and survive (Rossi et 
al., 2001). One of the targets of Cyclin H/Cdk7/Mat1 kinase is the Cyclin E/Cdk2 complex. It 
was suggested that in trophoblast cells, Cyclin E/Cdk2 might represent a targets of Cyclin 
H/Cdk7/Mat1, highlighting a critical role of Mat1 in the control of cell proliferation. Also, mice 
null for Mat1 gene represented the earliest embryonic lethality associated with the disruption of 
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genes important for cell cycle regulation. Interestingly the development of the inner cell mass in 
these embryos was dependent on the presence of Mat1, while post mitotic trophoblasts cell did 
not, suggesting that Mat1 is essential for the mitotic cell cycle.  
 
 
5. The role of Cdc25 proteins in G1 to S progression 
Three CDC25 genes have been identified in humans, all of which are subject to alternative 
splicing, suggesting the existence of a potentially wide array of CDC25 phosphatase activity. 
Recent evidence has demonstrated that all three CDC25 isoforms play essential roles during the 
G1-S and G2-M transitions, and in mitosis, where all three isoforms show specific activity 
towards Cdk1/cyclin B1. Cdc25A belongs to a family of phosphatases that are important 
regulators of Cdk activity in different phases of the cell cycle. Activation of Cdc25A proteins 
occurs upon phosphorylation by Cyclin/Cdk complexes (Hoffmann et al., 1994). Cdc25A has 
been shown to promote entry into S phase by dephosphorylating and activating Cyclin E/Cdk2 
and cyclin A/Cdk2 complexes (Figure 1A; Blomberg and Hoffmann, 1999). However, antisense 
and /or siRNA molecules that specifically target either Cdc25B or Cdc25C can inhibit S-phase 
progression in human cells, even in a presence of the functional Cdc25A (Turowski et al., 2003), 
suggesting that all three isoforms cooperate to promote S phase entry. Also, the activity of 
Cdc25A is high from the G1/S boundary to mitosis, which suggests a role in the completion of 
the cell cycle. Cdc25A has been proposed to be a target of c-Myc (Galaktionov et al., 1996). 
However, Cdc25A gene expression was unaffected in myc-/- cells (Bush et al., 1998). Therefore, 
it is not clear whether Cdc25A is a target of c-Myc or part of the mechanism by which 
CyclinE/Cdk2 activation is induced by c-Myc (Figure 1A).    
  
 
6. The role of c-Myc on cell proliferation and cell cycle regulation 
c-Myc is a cellular proto-oncogene associated with a variety of human cancers and it is strongly 
implicated in the control of cellular proliferation, programmed cell death, and differentiation 
(Grandori et al., 2000; Patel et al., 2004). c-Myc protein is a transcriptional factor with basic, 
helix-loop-helix  and leucine zipper domains (Mateyak et al., 1999). In addition to its role as a 
transcriptional activator, c-Myc has been also shown to participate in repression of transcription 
(Li et al., 1994; Penn et al., 1990). The expression of the c-Myc gene is closely correlated with 
cell growth, and removal of growth factor at any point of cell cycle results in its downregulation. 
c-Myc expression is absent in quiescent cells but  is rapidly induced upon the addition of growth 
factors (Figure 1A; Spencer et al., 1991). Overexpression of c-Myc in growing cells leads to 
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reduced growth factor requirements and a shortened G1 phase (Karn et al., 1989), whilst reduced 
c-Myc expression causes lengthening of the cell cycle (Shichiri et al., 1993). Various studies 
have a shown a role for c-Myc in increasing the expression of Cyclin E and A, repression of 
Cyclin D1 expression (Philipp et al., 1994; Solomon et al., 1995) as well as maintenance of 
Cyclin E/Cdk2 kinase activity by inducing the expression of a hitherto-unidentified p27 –
sequestering protein which allows Cyclin E/Cdk2 complex to remain active (Vlach et al., 1996). 
Further systematic analysis of key regulatory components in c-Myc -/- cells indicated that the 
absence of c-Myc reduces the activity of all Cyclin/Cdk complexes. In particular, 12-fold 
reduction was observed in the activation of Cyclin D1/Cdk4 and Cdk6 complexes.  Also, 
examination of CKIs showed that p16 expression was unchanged, but p21 expression was 
decreased, and p27 expression was elevated in c-Myc -/- cells (Mateyak et al., 1999).  c-Myc 
null fibroblasts isolated by target homologous recombination display a lengthening of both the 
G1 and G2 phases of the cell cycle, while duration of S phase remains unchanged (Mateyak et 
al., 1999), thus indicating an important role for c-Myc at multiple points during cell cycle 
regulation. Earlier it was reported that the level of c-Myc as a transcription factor oscillates as 
cells progress through the cell cycle and there is a marked increase in transactivation during the 
S-to G2/M transition. The regulation of transactivation potential can be accounted for, in part, by 
changes in the phosphorylation state of c-Myc, suggesting importance of its function at G2 stage 
of the cell cycle. 
 
7. Interactions between positive and negative regulators of the cell cycle  
Cyclin D/Cdk4-6 complexes are subject to negative regulation by both the Ink4 and Cip/Kip 
families of inhibitors, whilst the CyclinE/Cdk2 complexes are inhibited only by the Cip/Kip 
family. Cip/Kip inhibitors, such as p21Cip/Waf1, p27 Kip1 and p57Kip2 are balanced between 
Cyclin D/Cdk4,-6 and Cyclin E/Cdk2 complexes (Figure 1A). When Cyclin D expression is 
increased by mitogens, more p27Kip1 is bound to Cyclin D1, resulting in the redistribution of 
p27Kip1 from the Cyclin E/Cdk2 complex to a Cyclin D/Cdk4,-6 complex, thereby releasing 
Cyclin E/Cdk2 from the negative control of p27. Therefore, apart from their kinase function in 
phosphorylating Rb, the Cyclin D/Cdk4-6 complexes indirectly stimulate Cyclin E/Cdk2 
complexes by titrating out their inhibitors (Sherr and Roberts, 1999; Sherr and Roberts 1995). In 
addition, p21 and p27 have been shown to positively regulate CyclinD/Cdk4 complexes at low 
concentration by facilitating their assembly and possibly their nuclear translocation (Cheng et al., 
1999). Consistent with this MEFs lacking p21 and p27 showed low Cyclin D1/Cdk4 assembly 
and activity as well as lack of nuclear localization (Cheng et al., 1999). However, p21 and p27 
deficient MEFs do not exhibit cell cycle defects. At the same time, null mutations in p27 or 
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Cyclin D1 result in tissues global defects. As it was discuss above mice homozygous for null 
mutation in the Cyclin D1 gene are small indicating that all organs are affected. In contrast, 
p27Kip1 -/- mice exhibit multiorgan hyperplasia (Fero et al., 1996). Female p27-/- mice are 
infertile due to abnormal oestrous cycle, poor ovulation rate and a failure to produce estrogen 
(Tong et al., 1998). However, cyclin D1 null mice appear fertile (Sicinski et al., 1995). Taken 
together, these data suggest opposite action for Cyclin D1 and p27 in regulating rates of cell 
proliferation in vivo.  
 
In addition, loss of Cyclin D1 corrected the implantation defect of p27-/- females and also almost 
completely rescued the disorganization of the retinal structures, while loss of p27 restored the 
cellularity of the Cyclin D1-/- retinas.  This was achieved with only a partial restoration of 
phosphorylation of Rb protein and Cdk4 activity, but with dramatic elevation of Cdk2 activity, 
suggesting that p27 acts as a negative regulator of CyclinE/Cdk2 activity and that it can be 
titrated away by Cyclin D/Cdk4 complexes (Tong and Pollard, 2001). However, failure of corpus 
luteum cells to appropriately exit the cell cycle, the abnormal oestrus cyclicity, the incidence of 
pituitary adenomas associated with p27 loss argues for independent action of p27 in some 
tissues. 
 
8. The roles of retinoblastoma gene family 
 Retinoblastoma (Rb) is quite often regarded as a negative regulator of the cell cycle progression 
and a positive regulator of cellular differentiation. In the absence of growth stimuli, 
unphosphorylated Rb binds proteins such as E2F family members, as well as co-repressors that 
enable chromatin remodelling activities. Phosphorylation of Rb is specific for cycling cells and 
is proposed to inactivate its activity (Khidr and Chen, 2006).  
 
It is proposed that Rb1 (also known as p105), and its related family members (Rb2/p107 and 
Rb3/p130), maintain the critical G1 juncture. Cells in G0/G1 express Rb in un- or 
hypophosphorylated form. D-type cyclins trigger phosphorylation of Rb resulting in its 
inactivation and liberation of E2F factors, whose activity is required for entry in S phase (Figure 
1A; Sherr and Roberts, 1999). Accumulation of Cyclin E together with Cdk2 orchestrates the 
continued phosphorylation on Rb protein and leads to the release of E2F, thereby facilitating the 
activation of genes critical for S-phase progression.  
 
The Rb/EE2F complex consists of three Rb like proteins as outlined above and six E2F family 
members (E2F –1, -2, -3, -4, -5, -6) each of which can heterodimerize with two DNA-binding 
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protein partners (DP1 and DP2) to form 12 different DNA-binding transcriptional regulators 
(Cam and Dynlacht, 2003). E2F family members can be divided into two classes: activators 
(E2F1, E2F2, E2F3) and repressors (E2F4 and E2F5) of transcription. E2F6 is considered to be 
an independent member that lacks several functional domains, including the Cyclin – and pRb –
binding domains and the trans-activation domain (Trimarchi et al., 1998). Activator –E2Fs 
utilize Rb as their major binding partner, while repressor –E2Fs bind p130  with the exception of 
E2F4 which is shown to preferentially bind to p107 (Frolov and Dyson, 2004). The Rb/E2F 
complex can be detected in G1 phase and seems to play a critical role in G1 to S transition. 
Activator-E2Fs exist in free form during S-phase. The p130/E2F complex is most evident in 
quiescent cells and p107/E2F complex is present in both G1 and S-phases.  
 
Phosphorylation cascades in coordination with growth stimuli gradually mould Rb to release 
E2F in preparation for cell division. When cells are committed to eliciting the differentiation 
program, Rb needs to be removed or counteract differentiation inhibitors. Rb deficiency then   
leads to either apoptosis for cells committed to a specific differentiation program, or 
uncontrolled cell growth for cycling cells. To date, it is unclear how many functional Rb 
complexes exist. In addition, it is unclear how the Rb interacting proteins find Rb and how they 
execute their function. Does an Rb core complex exist while transiently associated members are 
recruited under specific growth and differentiation conditions in the cell? Or there are various Rb 
complexes, each participating in distinct processes (Khidr and Chen, 2006)? 
 
The expression of each Rb family protein differs according to cell status. Rb2/p130 is highly 
expressed in quiescent and differentiated cells and its levels drop rapidly when quiescent cells 
are stimulated to enter the cell cycle (Classon and Dyson, 2001). Moderate levels of Rb1/p105 
can be found in most cell types as well as in both quiescent and cycling cells. In vivo studies 
have demonstrated that Rb gene family members differ in their binding to the E2F family of 
transcription factors and fluctuation of this binding are seen throughout the cell cycle. Thus 
Rb2/p130 binds to E2F4 and 5 in G0 and Rb3/p107 is associated with E2F4 in G1, whereas 
Rb1/p105 binds to E2F4 in S phase (Howard et al., 2000). Like Rb1/p105, Rb3/p107 can inhibit 
proliferation of certain cell types, arresting cells in G1. It has been observed that “pocket 
proteins” share many functions, sometimes overlapping with one another in the cell cycle 
regulation; nevertheless, in vivo studies have proven that each of them also play very distinctive 
roles (Genovese et al., 2006). 
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Both Rb3/p107 and Rb2/p130 can stably interact in vitro and in vivo with cyclin A/Cdk2 and 
Cyclin E/Cdk2 complexes. Induction of pRb2/p130 inhibits Cyclin A- and Cyclin E-associated 
kinase activity. Through this inhibition, pRb2/p130 also induces p27 levels by impeding Cyclin 
E/Cdk2 phosphorylation of p27, which in turn generates the proteolytic degradation of p27 
(Howard, 2000). Moreover, Rb2/p130 possesses a kinase inhibitory domain in its spacer region 
that preferentially inhibits Cdk2 kinase activity (De Luca et al., 1997). Interestingly, both 
Cyclins A and E have been found to rescue Rb2/p130 induced cell cycle arrest, indicating the 
importance of this interaction in cell cycle progression (Claudio et al., 1996).  
 
Rb is also recruited to certain replication initiation sites after DNA damage, presumably to 
suppress abnormal replication activity (Avni et al., 2003). Several tumor suppressor proteins play 
key roles in the maintenance of an appropriate DNA damage response. The G1 checkpoint is 
disabled through a variety of mechanisms, such as loss of p16, loss of Rb, overexpression of 
Cyclin D1 or overexpression of Cdk4 (Sherr, 1996). Rb is crucial for the maintenance of the 
DNA damage checkpoint function because it elicits cell cycle arrest in response to a variety of 
genotoxic stresses. Cells lacking Rb are deficient for the G1 checkpoint response to DNA 
damage. DNA damage activates Rb by elevating its dephosphorylated form, potentially through 
the p53 pathway (Bosco and Knudsen, 2005). In addition, Rb has been localized to sites of DNA 
replication early in S phase. Rb plays a role in S-phase arrest in cells that have encountered a 
high dose of DNA damaging agents, such as mitomycin C (Bosco and Knudsen, 2005). In fact, 
the Rb protein is dephosphorylated in S-phase cells following DNA damage. Rb may also 
regulate the progression through S phase via its interaction with the SWI/SNF complexes 
(Genovese et al., 2006). The initiation of G2 checkpoint is an Rb –independent event, but Rb is 
required for maintenance of G2 arrest. Rb becomes activated in G2 arrested cells following a 
high dose of irradiation through p53 and p21. The extended G2 arrest in the Rb +/+ cells 
correlates with a gradual accumulation of hypophosphorylated Rb that it is believed to be 
initiated by radiation induced damage initiate signalling pathways that lead to Rb-
dephosphorylation (Naderi et al., 2002).  
 
pRb2/p130 and p107 are also critical regulators in the expression of G2/M  required genes, e.g. 
Cdk1 and Cyclin B1 ( Jackson et al., 2005). Thus, Rb is essential not only in the regulation of the 
proliferation-promoting factor E2F but also in preventing DNA damage accumulation (Genovese 
et al., 2006). Also, studies focusing on the overexpression effects of Rb3/p107 protein in 
fibroblasts demonstrated a subsequent inhibition of Cdk2 activation and a marked delay in S 
phase entry (Rodier et al., 2005). The inhibition of Cdk2 activity is correlated with the 
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accumulation of p27. It is speculated that p27, an inhibitor of Cdk2, indirectly triggers Rb 
hypophosphorylation in late G1. Association between p27, pRb2/p130 and Cyclin E have been 
shown by immunoprecipitation assays (Paggi and Ciordano, 2001).  It is therefore likely that p27 
binds the Cyclin E/Cdk2 complex causing a decrease in Cyclin E/Cdk2 activity which results in 
the hypophosphorylation of Rb1/p105 and Rb2/p130 in late G1. Induction of Rb2/p130 
expression results in inhibition of Cyclin E –associated kinase activity that induces p27 levels by 
preventing its degradation (Howard et al., 2000). Also, Rb2/p130 and Rb3/p107 contain  a motif 
similar to the one found in the p21/Cdk-inhibitor, which grants the ability to bind and inhibit 
Cdks , suggesting that pRb3/107 and pRb2/p130 may also be responsible for an interaction that 
affects Cdk activity (Woo et al., 1997). Rb2/p130 uniquely also possesses another distinct kinase 
inhibitory domain, found within its spacer region, which selectively inhibits Cdk2 kinase activity 
(De Luca et al., 1997; Howard et al., 1998). 
 
Mice lacking Rb show several defects in hematopoesis and myogenesis are greatly impaired (Lee 
et al., 1992, Lee et al. 1996). Murine embryos that lack both copies of the Rb gene have dividing 
neural precursor cells outside the normal neurogenic regions in both the central and peripheral 
nervous systems (Lee et al., 1992). Embryos lacking both Rb2/p130 and Rb3/p107 died in utero 
2 days earlier than Rb1-deficient embryos (Lee et al., 1996). Disruption of Rb family members 
in MEFs induces loss of G1 control and immortalization (Sage, at al.,2000). MEFs that lack 
expression of all three Rbs are completely insensitive to senescence-inducing signals, show a 
strong increase in their proliferation rate, deregulate G1 phase and become immortal 
(Dannenberg et al., 2000). Many human cancer cells have mutation in one or more components 
of p53 and Rb pathways (Galderisi et al., 2006).   
 
9. The role of HiNF-P/p220 NPAT complex in G1 to S phase transition 
During S phase, newly synthesised DNA needs to be packaged into nucleosomes. It is therefore 
reasonable to expect that de novo synthesis of histone mRNA and protein occurs at the G1 to S 
phase transition. Recent data (summarised in the review by Stein et al. 2006) suggests that this 
process is functionally, temporally and spatially distinct to the transcriptional mechanisms that 
occur during R point.  
 
The human histone H4 gene promoter has been extensively used as an exemplary model to 
illustrate the factors that regulate the synthesis of the four core histone proteins and it is for this 
reason that we will concentrate on its role during this review. One of the most critical factors that 
regulates histone H4 gene transcription is histone nuclear factor P (HiNF-P).  HiNF-P is a Zn-
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finger transcription factor containing an N-terminal binding domain that has been shown to 
recognise a large consensus sequence within histone H4 genes (Mitra et al. 2003; Aziz et al., 
1998). The HiNF-P expression is constitutive during the cell cycle (Pauli et al. 1987), but its 
DNA binding activity and expression are downregulated during differentiation of HL60 cells, 
suggesting a role for this gene in proliferating cells (Howhannisyan et al. 2003). 
 
The HiNF-P activation of H4 genes is dependent on the p220NPAT (nuclear protein mapped to the 
ATM locus) which has been shown to be a direct target of the Cyclin E/Cdk2 signalling (Figure 
2A; Imai et al. 1997). Genetic characterisation of the HiNF-P promoter has shown that HiNF-P 
is activated  by both HiNF-P and p220NPAT and this activation is further enhanced by Cyclin E 
and Cdk2 activity and inhibited  by p57Kip2, p21CIP and p27Kip1 (Xie et al. 2007). These studies 
have also shown that p220NPAT can stimulate HiNF-P not only with HiNF-P itself but also with 
Sp1, p300 and CBP; however this stimulation is antagonised by E2F1 activity (Xie et al. 2007). 
The dependency of HiNF-P in transactivation of histone H4 genes on the Cyclin E/Cdk2 
complex suggests that synthesis of H4 histone proteins is also cell cycle dependent.  
 
11. Cell cycle regulation in murine and primate ESC 
ESC are a population of pluripotent, self renewing cells that are derived from the epiblast of 
mammalian blastocysts (Hyslop et al. 2005). ESCs have the potential to differentiate to 
functional cell types of all three germ layers in vitro and upon integration into animals have the 
capacity to contribute to all cell types of the embryo (Stojkovic et al. 2004). These cells can 
proliferate without apparent limit and can be readily propagated, however very little is known 
about these unusual proliferative properties, their cell cycle structure and how this affects the 
pluripotent phenotype.  
 
Studies carried out in murine and primate ESC have shown that the cell divisions are very short 
and their division is controlled through unusual mechanisms of Cdk regulation. Rapid division of 
these cells is associated with an unusual cell cycle structure composed of a rather large S phase 
and a truncated G1 phase (Savatier et al., 1994; Fluckiger et al., 2006). Murine ESC lack the cell 
cycle dependent Cdk4 and 6/Cyclin D as well as Cdk2/Cyclin E activity that is associated with 
G1 to S transition in normal somatic cells, however this is activated immediately upon 
differentiation (Figure 2B). The only cell cycle regulators that show cell cycle dependent 
expression are Cdk1 and Cyclin B1 and this occurs at G2 phase (Stead et al. 2002). At the 
molecular level this is underpinned by high and constant levels of Cdk2/Cyclin E complex, low 
levels of p21Cip1 and p27Kip1 CDK inhibitors and almost undetectable levels of Cyclin D/Cdk4 
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activity (Stead et al. 2002; Savatier et al. 1996). Cyclin D3 and Cyclin D1 are expressed at 
modest levels in murine ESC; however Cdk6/Cyclin D3 activity is relatively high due to 
resistance of p16INK4a inhibition (Faast et al. 2004). While these cells express the cell cycle 
pocket proteins, Rb1/p105 and Rb3/p107, they are hypophosphorylated and held in a 
biochemically inactive state presumably due to the activity of cell cycle independent pRb kinase 
activity (Stead et al. 2002). In addition, pRb is not found in complexes with E2F transcription 
factors and E2F dependent transcription lacks cell cycle periodicity (Humbert et al. 2000). As 
these cells differentiate the length of G1 phase increases substantially and this is associated with 
the establishment of cell cycle dependent Cdk2 activity and activation of a functional Rb-E2F 
pathway (White et al. 2005).  Similar studies have shown that primate ESC exhibit a non phasic 
expression of Cyclin E and do not growth arrest in G1 after gamma irradiation, reflecting the 
absence of G1 checkpoint signalling (Fluckiger et al., 2006). 
 
In murine ESCs, the Rb1/p105 and Rb3/p107 proteins are hyperphosphorylated and inactive. 
Consequently, E2F responsive genes are transcribed independently of cell cycle progression 
(Stead et al., 2002; White et al., 2005). Loss of pluripotency and stemness is associated with 
decreased Cdk activity and activation of Rb pathway (White et al., 2005). However, little is 
known about the role of Rb3/p107 and Rb2/p130 in stem cell biology. It was shown that 
inactivating disruptions in Rb1/p105 together with Rb3/p107 and Rb2/p130 do not seem to 
compromise ESC proliferation, but they reduce differentiation in experimental teratocarcinomas. 
This indicates that Rb dependence is only acquired as ESC undergo differentiation (Dannenberg 
et al., 2000; Sage et al., 2000). In addition, it has been reported that ESC share some similarities 
in proliferative behaviour with MEFs which are triple knockout to three Rb family members 
(Rb1-/-, Rb2-/-, Rb3-/-). Both triple knockout MEFS and ESC fail to arrest in G1 at confluence 
and after DNA damage, while in normal cells, growth arrest in G1 is strictly dependent on a 
functional Rb pathway (Prost et al., 1998; Harrington et al., 1998; Brugarolas et al., 1999). 
Hence, lack of Rb control in G1 in ECS, suggested that c-Myc pathway could play a critical role 
in regulation of G1 to S phase transition. 
 
Similar functional differences for Rb family members have also been reported in other stem cell 
types (Caputi et al., 2005). For example, regulation of cell cycle progression by both Rb1/p105 
and Rb2/p130 was observed both in mesenchymal stem cells (MSCs) grown as undifferentiated 
cells and in those committed toward neural phenotype, suggesting that Rb1 and Rb2 have 
overlapping activities in cell cycle regulation (Galderisi et al., 2006). In addition, while the 
antiproliferative activity of Rb is mainly HDAC-independent the cell growth arrest induced by 
 17 
Rb2/p130 relies at least in part on HDAC related pathway (Jori et al., 2005). In neural stem cells 
(NSCs) overexpression of Rb1/p105 and Rb2/p130 promotes significant variations of 
differentiation process towards neurons, astrocytes and oligodendrocytes (Jori et al., 2005). Also, 
it was shown that Rb3/p107 plays a role in the expansion of neural stem cells (NSCs) shown by 
higher numbers of secondary neurospheres generated from p107 null primary neurospheres, thus 
demonstrating a novel role for Rb3/p107 that is distinct from Rb1/p105 and Rb2/p130 
(Vanderluit et al., 2004).            
    
12. Cell cycle regulation in human ESC 
Recent work carried out in our group has shown the presence of CDK2, CDK4, CDK6, CYCLIN 
D1, CYCLIN D3, CDC25A and c-MYC in human ESC (Neganova et al. in preparation, Zhang et 
al. in preparation). Most importantly, immunoprecipitation studies have shown the presence of 
CYCLIN D1 and D3/CDK6, CYCLIN D1 AND D3/CDK4 complexes as well as 
CDK2/CYCLIN E, CDK2/CDC25A and CDK2/c-MYC complexes (Neganova et al. in 
preparation). CYCLIN D3 and D2 expression increases upon differentiation, whilst CYCLIN A 
expression decreases during this process. We found that human ESC express CYCLIN E, but 
with the start of differentiation towards EBs, CYCLIN E expression is upregulated. Also, 
expression of CDK2 was significantly downregulated by day 10 of EB development. The level 
of CIK (p15, p16, p19, p18, p21, p27) is very low and in some cases absent (Zhang et al. in 
preparation; Neganova et al. in preparation) and both phosphorylated and unphosphorylated 
forms of RB1/p105 are present (Figure 1B and 2C). The low level of inhibitors is in some cases 
achieved by high expression of proteins that secure their ubiquitin dependent degradation. For 
example, p27 expression in human ESC is low; however the expression of the ubiquitin ligase, 
Skp2 is high (Egozi et al. 2007). Also, in contrast to somatic cells, which have high levels of 
Skp2 during S and G2 /M phases , in undifferentiated hESC Spk2 levels were also high at G1 
phase of the cell cycle ( Egozi et al., 2007).  Similarly to murine ESC, the embryoid bodies 
(EBs) with low p27 expression and high Skp2/p27 ratio showed poorer differentiation than those 
with high p27 expression (Egozi et al. 2007; Bryja et al. 2005), suggesting an important role for 
p27 during differentiation process that is likely to be linked to its role in cell cycle regulation.  
 
In contrast to murine ESC, we found that quite a few of the components involved in cell cycle 
regulation showed cell cycle dependent expression. For example, CDK2 showed highest 
expression in the S phase, CYCLIN A and c-MYC in S and G2 phase, CYCLIN B1 in G2 phase, 
CYCLIN E in G1 and S phase, whilst CDC25A in G1 phase of the cell cycle (Figure 2C). These 
results differ slightly to recent reports by Ghule et al. 2007 in which only CYCLIN A and E were 
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shown to be preferentially upregulated in early S phase. This could be due to the differences in 
the methods used to synchronise human ESC in particular stages of the cell cycle as well as 
omission of late S phase and G2 in the later study. Despite the discrepancies between the two 
studies, one important fact is emerging that regulation of these proteins is very different during 
the cell cycle of murine and human ESC. 
 
Our own studies have also shown a functional role for CDK2, CDC25A and CDK6 in G1 to S 
transition in human ESC (Neganova et al. in preparation; Zhang et al. in preparation). For 
example downregulation of CDK2 results in accumulation of cells in G1 phase of the cell cycle, 
increase in p21 and p27 expression and induction of differentiation (Neganova et al. in 
preparation). Downregulation of CDK6 increases the timing needed for G1 to S transition, whilst 
downregulation of CDC25A interferes with human ESC progression along the S phase of the cell 
cycle (Zhang et al. 2007; in preparation). Upregulation of either CDK6 or CDC25A results in 
shortening of G1 to S transition and it is likely that this is dependent on Rb-E2F pathway, though 
more work is needed to prove this hypothesis (Zhang et al. in preparation). 
 
Work done in other somatic stem cells has indicated that CDK4, CDK6 and CDK2 are expressed 
in neuronal progenitor cells and downregulated upon their differentiation (Ferguson et al., 2000). 
CDK4/CDK6 activity and phosphorylation of Rb have been shown to be essential for S phase 
entry in neuronal progenitor cells, thus suggesting that this cell type follows the normal 
canonical pathway for cell cycle regulation. Expression of Cdk6 in mouse astrocytes has also 
been associated with expression of progenitor cell markers, indicating that Cdk6 might have a 
more widespread role in cell fate differentiation than just in the cell cycle regulation as 
previously thought (Ericson et al., 2003; Grossel and Hinds, 2006). This hypothesis is supported 
by a number of further studies that show down-regulation of Cdk2 and Cdk6 activity upon 
differentiation of murine erythroid leukaemia cells (Hsieh et al, 2000). Taken together these data 
suggest some similarities between cell cycle regulation in embryonic and cancer cells. 
 
The role of different RB/E2F complexes and the factors that determine which RB/E2F complex 
will bind to and regulate E2F response remains uncertain for human ESC. A recent report has 
shown that p105 responsive E2F members (E2F1, E2F2 and E2F3) are expressed at lower levels 
than E2F4, E2F5 and E2F6. E2F1, E2F2 and E2F3 together account for 17-24% of total E2F 
activity in hESC, thus indicating that inhibitory E2Fs are more prominently expressed in hESC 
than in somatic cells. Especially, E2F5 and its cognate pocket protein RB2/p130 are the most 
abundant members of their class in human ESC (Becker et al. 2007). These data have led to 
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suggestions that human ESC show a decreased reliance on E2F-RB1 pathway that characterises 
the R point in somatic cells. It has to be emphasised that these data are only carried out at the 
transcriptional level and it is unclear whether this is true at the protein level. In addition, 
abundance or low expression of a particular gene cannot tell much about function; thus 
functional studies to highlight the role of each RB and E2F factor in human ESC are desperately 
needed.  
 
Recent data suggest that the “S point pathway” is also operative in human ESC (Figure 2C; 
Ghule et al. 2007). Cell synchronisation experiments coupled with immunofluorescence 
microscopy showed a duplication of p220NPAT foci prior to onset of DNA synthesis unlike 
normal somatic cells where such event is evident only in S phase. In addition, it has been shown 
that histone H4 gene, HiNF-P and  p220NPAT expression in human ESC is DNA replication 
dependent unlike somatic cells where HiNF-P and p220NPAT expression is constitutive. It is likely 
than that the availability of mRNAs for these important components of S point pathway forms 
one of the mechanisms that control cell cycle dependent gene expression in human ESC (Becker 
et al. 2007). Functional assays remain to be carried out to prove the functionality of S point 
pathway in these cells. 
 
An important aspect of cell cycle regulation is the presence of check point – apoptosis signalling 
that prevents the accumulation of genomic damage in these cells. DNA damaging agents, 
including UV irradiation in human ESC has shown to result in apoptosis. p53 protein 
accumulates in the apoptotic cells, however it fails to activate the transcription of its target genes 
(Qin et al. 2007). Results from this paper show that the p53 induced apoptosis pathway is 
mediated via the mitochondrial pathway. Downregulation of p53 is also shown to result in 
reduction of spontaneous differentiation of human ESC; whilst its accumulation can induce 
differentiation by suppressing the transcription factor OCT4 and NANOG (Qin et al. 2007). 
Another report has suggested that gamma irradiation results in p53 dependent transactivation of 
the CDK inhibitor p21CIP1 resulting in cell cycle arrest in human ESC (Becker et al. 2007). This 
indicates that at least the p53 checkpoint signalling is closely linked to the maintenance of 
pluripotent phenotype. This mechanism provides a protective role for human ESC by inducing 
differentiation, cell cycle arrest or apoptosis of those ESC that have suffered DNA damage in 
order to eliminate them from the undifferentiated stem cell pool. In spite of the presence of such 
protective mechanisms, human ESC have been shown to accumulate chromosomal abnormalities 
(Draper et al. 2004). New studies have revealed that the mitotic spindle checkpoint which helps 
to maintain chromosomal integrity during cell divisions functions in human ESC but does not 
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initiate apoptosis as it does in somatic cells. This allows an unusual tolerance to polyploidy 
resulting from failed mitosis which is also characteristic to human cancers (Mantel et al. 2007). 
The uncoupling therefore of spindle checkpoint from apoptosis is likely to provide one of the 
causes of karyotypic abnormalities in human ESC. 
    
13. The role of key pluripotency factors in cell cycle regulation 
Oct4, Sox2 and Nanog are key regulators shown to be essential for the formation and 
maintenance of the inner cell mass during mouse and human preimplantation development and 
for the self-renewal of pluripotent ESC (reviewed by Chambers and Smith, 2004). Recent large 
scale transcriptional and posttranscriptional studies have identified a number of interactions 
between these pluripotency factors. For example, it has been shown that Oct4 and Sox2 bind to 
the Nanog promoter in vitro and in vivo (Rodda et al., 2005). Further mutagenesis studies shows 
that Oct4/Sox2 motif is required for the activity of Nanog promoter in pluripotent cells (Kuroda 
et al., 2005), suggesting that Oct4 and Sox2 act to promote Nanog transcription in ESC cells. 
However, in Oct4 deficient embryos, Nanog expression is detected, suggesting that Nanog can 
be maintained without Oct4 (Chambers et al., 2003) and that other pluripotent factors may 
contribute to the regulation of Nanog expression. FoxD3, a forkhead family transcription factor, 
is highly expressed in mESC and in pluripotent cells of the early embryo (Sutton et al., 1996). 
FoxD3 null mouse embryos die shortly after implantation due to the loss of the epiblast, a 
phenotype which is quite close to the Nanog deficient embryos (Hanna et al., 2002). 
Interestingly, it has been shown that FoxD3 can activate the Nanog promoter (Pan et al., 2006).   
 
Boyer and colleagues identified DNA regions bound individually by OCT4, NANOG and SOX2 
in human ESC and showed the high frequency of co-occupancy within the same gene region by 
these three factors (Boyer et al. 2005). Among OCT4 bound genes, half of them are also bound 
by SOX2. Moreover, about 90% of the promoter region bound by OCT4 and SOX2 are also 
bound by NANOG. Recently a negative feedback loop formed by Nanog, Oct4 and FoxD3 was 
described (Pan et al., 2006). It was shown that Oct4 maintains Nanog expression by directly 
binding to the Nanog promoter when present at a sub-steady level, but represses it when Oct4 is 
above the normal level. On the other hand, FoxD3 positively regulates Nanog to counter the 
repression effect of excess Oct4. Conversely, Nanog and FoxD3 function as activators for Oct4 
expression. When the expression level of Oct4 rises above a steady level, it represses its own 
promoter as well as Nanog thus exerting a negative feedback regulation loop to limit its own 
expression (Pan et al., 2006). This negative feedback regulation loop keeps the expression of 
Oct4 at a steady level, thus maintaining the ESC properties. Overall, these data suggest that the 
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key pluripotency factors always work together, rather than individually, to control a whole set of 
target genes, as well as each other, to maintain the pluripotency of ESC (Pan and Thomson, 
2007).  
 
Results recently obtained in our group have shown that NANOG overexpression enhances the 
G1 to S transition. This results in shortening of the time needed for G1 to S transition and causes 
an increase in numbers of cells in S phase (Zhang et al., 2007, in preparation). This is achieved 
by direct binding of the C terminal domain of NANOG to the regulatory regions of CDK6 and 
CDC25A in human ESC (Figure 1B). This example provides the first evidence that key 
pluripotency factors regulate the cell cycle transition in human ESC. 
 
Oct4 has also been shown to regulate genes linked to cell cycle progression (Campbell et al., 
2007). Oct4 knockdown results in downregulation of genes involved in proliferation and an 
increase in the cell cycle inhibitor p21 and expression of p63, which has been linked to 
differentiation (Keyes al., 2005). Knockdown of OCT4 in MSCs appears to shift cells from a 
cycling to a non-cycling state and what is of a great importance this paper showed  that in human 
MSCs as well as in ESC, CDK4 and CDC25A transcription is regulated by OCT4 (Figure 1B; 
Greco et al., 2007).  
 
A recent paper (Becker et al. 2006) has shown that human ESC have a short G1 phase compared 
to somatic cells. In addition, lengthening of G1 in neural stem cells by inhibition of Cdks results 
in differentiation (Calegari and Huttner, 2003), suggesting that the longer the stem cells stay in 
G1, the more likely they are to be subjected to differentiation signals. In support of this it was 
shown that murine embryonic carcinoma cells are particularly vulnerable to retinoic acid induced 
differentiation while they progressed from mitosis to the next S phase, but became refractory to 
this differentiation while in S phase (Mummery et al., 1986). These observations suggest that G1 
phase corresponds to a window of increased sensitivity to differentiation signals. The regulation 
therefore of G1 to S transition of ESC by master pluripotency factors such as Oct4 and Nanog 
and perhaps the subsequent shortening of the G1 phase ensuing from this, shields the ESC from 
activities that will induce their differentiation (for a schematic representation see Figure 3).  
 
Conclusions 
During the resent years intensive investigation of mice lacking one or more cell cycle genes have 
increased our understanding of cell cycle machinery. At the same time, these mouse models have 
revealed that a large number of these proteins are dispensable for cell proliferation in a number 
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of cell types and in some cases for the embryonic development. An important lesson that can be 
drawn from these studies is that the cell cycle machinery operates differently in distinct cell 
types and that compensatory mechanisms exist to allow somatic cells to proliferate in the 
absence of a given cell cycle regulator. Whether this holds true for embryonic stem cells is as yet 
unknown since the cell cycle studies in human ESC are still in their infancy. Quite a few key 
differences have emerged between the cell cycle regulation in murine and human ESC. One 
speculative interpretation of these findings that takes into account the immediate upregulation of 
CDK/cyclin D activity in murine ESC upon their differentiation would be that human ESC are 
more similar to early differentiated murine ESC where the more sophisticated cell cycle 
dependent CDK/Cyclin D mechanisms are established. Indeed, new studies have shown that 
human ESC are more similar to the pluripotent cell lines derived from the post implantation 
epiblast (Brons et al. 2007; Tesar et al. 2007). In addition, new techniques have shown that 
human ESC contain two distinct cell populations that differ in their cell surface and transcription 
factor expression as well as their cell cycle regulation (Mantel et al. 2007; Stewart et al. 2006). 
Any differences therefore between human and murine ESC have to be explored with caution in 
these two reported populations before firm conclusions on their basic biology can be drawn up in 
the text books in years to come. 
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Figure Legends 
 
Figure 1.  Simplified schematic representation of the key molecular pathways controlling 
G1 to S phase transition in somatic cells (A) and in human ESC (B). In proliferating cells, Rb 
phosphorylation by Cyclin/Cdk complexes releases E2F, which then induces genes that mediate 
S phase entry. Arrows indicated stimulatory modifications, blocked lines show inhibitory 
modifications. – p and + p indicate removal and addition of phosphorylation respectively. ? 
indicates scientific questions that have not been addressed as yet. 
 
Figure 2. A simplified presentation of the fluctuation of expression of Cyclins and Cdks 
involved in G1 to S progression in somatic cells (A), mouse ESC (B), and human ESC (C).  
R and S point are shown in red. 
(A) – Activity of Cyclin/Cdk complexes at different stages of cell cycle in somatic cells. 
(B) –Expression of Cyclin D, Cyclin E and Cyclin A is not dependent on the cell cycle 
progression in murine ESC. Hyperphosphorylated Rb is present at all cell cycle stages and the 
only Cyclin that demonstrates cell cycle periodicity in mouse ESC is Cyclin B1 at G2 stage of 
the cell cycle (not shown). Although it is clear that R point does not operate in murine ESC, the 
existence of a functional S point and G2/M is not clear. Recent investigations suggest that 
although the mitotic-spindle checkpoint, which helps maintain chromosomal integrity during all 
cell divisions, functions in human and mouse ESCs, it does not initiate apoptosis as it does in 
somatic cells. 
(C)- Expression of Cyclins in human ESC during cell cycle progression. Cyclin D1 is constant 
throughout the cell cycle, but the level of Cyclin E is higher during G1-S phases and Cyclin A is 
high at S-G2 stages of the cell cycle. Cyclin B1 expression is also higher at the G2/M stage (data 
not shown). Recent investigations have indicated the existence of S point; however it remains to 
be determined whether the R and G2/M points are functional in these cells. 
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